AKT1 and cancer: In addition, loss of function of POU5F1 remarkably restrains propagation, metastasis, and aggression of cancer stem cells through inhibition of the PI3K/Akt pathway, from which we could expect POU5F1 to be an underlying target for cancer therapy.87